Gene Query: TSPAN5

Dataset Description Geneva Score
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 129.28
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 56.51
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 54.3
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 54.12
RNA sequencing of BT142 and TS603 cell lines 54.12
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 49.26
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 49.26
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 41.83
RNA expression following TMPRSS11B overexpression or depletion 37.31
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 34.65
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 34.34
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 33.45
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 32.07
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 31.82
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 31.12
Differentially expressed genes post knock down of lincDUSP26 30.56
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 30.25
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 30.15
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 29.88
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 27.61
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 27.54
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 27.53
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 27.42
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 26.27
Developmental stage specific chromosome architecture in human erythroid cells 26.27
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 26.16
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 25.95
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 25.33
Patient-derived luminal breast cancer xenografts with progestins 25.33
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 24.82
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 24.08
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 23.73
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 23.11
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 23.11
Identification of long noncoding RNAs regulated by p53 22.97
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 22.52
Random mono-allelic expression in MECP2-mutated cells 22.36
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 21.83
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 21.69
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 21.69
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 21.37
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 21.09
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 20.98
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 20.83
ARID1A and ARID1B loss in HCT116 cells 20.45
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 20.2
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 20.03
Crizotinib v. DMSO in SW480 cells 19.85
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 19.63
Gene Expression Profiling of WT and KDM3A Knocked out Cell 19.08
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 19.08
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 18.86
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 18.85
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 18.74
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 18.52
Generation of KRAS signatures using immortalized isogenic lung cells. 18.46
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 18.38
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 18.36
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 18.2
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 18.2
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 18.12
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 18.1
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 18.1
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 18.01
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 18.01
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 17.67
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 17.44
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 17.41
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 17.39
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 17.25
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  17.08
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 17.01
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 16.89
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 16.86
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 16.83
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 16.83
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 16.83
PGE2 mediated gene expression changes in human cervical stromal cells 16.65
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 16.64
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 16.64
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 16.63
High level DNA repair gene expression in human ES cells 16.62
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 16.57
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 16.18
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 16.13
MYCi975 regulates MYC target genes 16.12
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 15.95
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 15.95
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 15.84
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 15.78
MicroRNA targetome analysis during HCMV infection 15.78
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 15.72
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 15.62
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 15.12
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 15.07
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 15.06
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 14.99
Paxillin regulates genomic networks in prostate cancer [LNCaP] 14.91
The effect of Abl kinases on non-small cell carcinoma global transcriptome 14.9
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 14.86
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 14.86
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 14.84
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 14.84
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 14.63
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 14.53
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 14.37
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 14.33
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 14.31
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 14.27
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 14.07
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 14.07
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 14.05
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 14.04
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 14.03
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 13.89
Identification of global regulators of T-helper cell lineage specification 13.89
STRIPAK directs PP2A activity to promote oncogenic transformation 13.81
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 13.35
Statins modulate endothelial transcriptional profile by inhibiting EZH2 13.28
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 13.27
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 13.26
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 13.25
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 13.25
Transcriptome profiling of Normal and Cancerous Prostate Cells 13.22
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 13.14
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 13.14
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 13.04
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 13.02
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 13.01
Short and Long RNA sequencing of human mature erythrocytes 13.01
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 12.95
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 12.9
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 12.89
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 12.64
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 12.58
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 12.56
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 12.56
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 12.56
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 12.55
The effect of PPARG inhibition on human angiomyolipoma cells 12.54
Tumor exosome integrins determine organotropic metastasis 12.43
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 12.41
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 12.41
RNA-seq analyses of human prostate cancer cells 12.22
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 12.16
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 12.14
Selective suppression of endothelial cytokine production by progesterone receptor 12.14
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 12.14
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 12.08
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 12.08
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 12.08
Generation of trichogenic adipose-derived stem cells by expression of three factors 12.03
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 12.0
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 11.99
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 11.97
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 11.84
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 11.79
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 11.76
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 11.74
Expression profiling of etoposide-induced senescent cells 11.63
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 11.6
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 11.57
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 11.57
Regulation of highly expressed hCINAP on translatome 11.54
Differential expression of genes in AD169-infected MRC5. 11.46
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 11.42
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 11.36
Endothelial gene expression analysis 11.36
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 11.3
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 11.3
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 11.29
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 11.26
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 11.25
RNAseq of T-ALL upon long non coding rna purturbation 11.22
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 11.14
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 11.11
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 11.09
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 11.09
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 11.08
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 11.08
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 11.01
A role for ZNF598 in post-transcriptional gene regulation 11.0
Expression level comparison under dividing and quiescent states in human primary fibroblasts 10.86
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 10.79
Global expression profiles in cardiac progenitor cells generated by ISX-9 10.79
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 10.79
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 10.78
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 10.72
The interplay between SOX4 and SMAD3 in the context of breast cancer 10.7
JunB control of keratinocyte-mediated inflammation [RNA-seq] 10.67
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 10.67
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 10.62
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 10.62
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 10.62
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 10.61
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 10.61
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 10.61
Chromatin landscape of human visceral and subcutaneous adipocytes 10.57
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 10.55
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 10.47
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 10.47
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 10.44
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 10.33
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 10.33
UBC9 knockdown in bladder cancer T24 cell lines 10.29
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 10.27
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 10.21
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 10.21
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 10.17
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 10.12
RNA-seq of human fibroblasts after irradiation 9.99
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 9.97
CDK12 mediated transcriptional regulation in U2OS cells 9.89
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 9.87
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 9.85
Ribosomal footprinting of MDA-Parental and MDA-LM2 9.82
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 9.78
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 9.65
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 9.65
CD95/Fas ligand mRNA is toxic to cells 9.65
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 9.62
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 9.61
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 9.6
RNA-seq of young and quiescent MRC-5 human fibroblasts 9.5
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 9.48
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 9.43
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 9.42
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 9.35
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 9.33
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 9.31
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 9.31
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 9.28
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 9.23
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 9.22
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 9.17
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 9.17
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 9.13
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 9.08
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 9.08
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 9.06
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 8.92
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 8.87
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 8.85
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 8.8
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 8.77
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 8.76
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 8.74
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 8.69
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 8.69
TCF7L1 knockdown in pancreatic cancer 8.66
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 8.65
Gene expression profiling of human and murine in vitro muscle differentiation 8.62
MCF10A H-Ras RNA-Seq 8.61
Ectoderm specification of H1 human embryonic stem cells 8.59
TGF-β promotes genomic instability after loss of RUNX3 8.58
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 8.57
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 8.55
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 8.53
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 8.49
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 8.49
X-Ray induced DNA-Hydroxymethylation changes 8.46
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 8.41
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 8.39
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 8.24
Ribosomal footprinting of CN34-Parental and CN34-LM1a 8.22
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 8.22
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 8.14
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 8.07
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 8.07
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 8.05
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 7.98
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 7.92
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 7.89
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 7.88
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 7.87
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 7.84
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 7.83
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 7.82
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 7.8
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 7.8
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 7.78
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 7.76
RNA seq comparison between scrambled and shGRP78 cells 7.74
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 7.72
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 7.71
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 7.7
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 7.69
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 7.65
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 7.64
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 7.6
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 7.52
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 7.5
RNAseq Analysis in glioblastoma cells treated with Mepazine 7.49
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 7.48
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 7.43
SLIGRL-induced gene expression changes in NHEK cells 7.41
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 7.4
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 7.4
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 7.33
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 7.15
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 7.13
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 7.08
Cerebellar differentiation in Ataxia-Telangiectasia 7.01
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 7.0
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 6.94
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 6.89
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 6.87
Real-time observation of light-controlled transcription in living cells 6.85
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 6.77
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 6.77
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 6.74
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 6.74
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 6.65
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 6.65
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 6.61
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 6.55
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 6.55
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 6.36
CHCHD2 gene KO effect in iPSC drived motor neurons 6.28
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 6.11
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 6.1
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 6.1
Gene expression profile in breast cancer cell lines using RNA sequencing 6.07
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 6.03
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 5.99
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 5.89
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 5.86
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 5.8
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 5.79
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 5.79
Next Generation Sequencing of human SMA and healthy control Motor Neurons 5.66
Differential gene expression in Jagged1 treated human dental pulp cells. 5.6
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 5.57
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 5.52
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 5.5
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 5.5
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 5.46
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 5.41
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 5.4
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 5.38
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 5.38
Induced DNA demethylation, genome instability and transcription 5.29
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 5.29
RNA seq_PDX2_SHP099 5.28
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 5.28
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 5.03
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 5.03
Activity-dependent transcriptional changes in human neurons 5.01
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 4.96
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.87
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 4.85
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 4.84
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 4.81
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 4.81
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 4.81
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 4.78
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 4.75
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 4.75
Repurposing of promoters and enhancers during mammalian evolution 4.74
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 4.7
CDK4/6 inhibitor resistance in prostate cancer 4.69
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 4.67
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 4.62
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 4.6
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 4.48
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 4.45
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 4.45
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 4.43
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 4.39
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 4.32
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 4.32
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 4.29
Aging-associated patterns in the expression of human endogenous retroviruses 4.22
Modeling Familial Cancer with iPSC Approaches 4.16
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 4.16
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 4.13
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 4.13
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 4.12
Metabolism as an early predictor of DPSCs aging 4.11
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 4.0
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 4.0
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 3.94
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 3.94
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 3.9
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 3.89
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 3.82
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 3.82
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 3.81
RNA-sequencing in immortalized human mammary epithelial cells 3.77
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 3.77
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 3.72
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 3.71
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 3.63
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 3.59
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 3.57
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 3.57
Morphological and molecular characterization of human dermal lymphatic collectors 3.47
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 3.44
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 3.39
RNAseq in Alzheimer's Disease patients 3.33
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 3.32
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 3.32
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 3.32
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 3.26
Finding missing proteins from epigenetically manipulated human cells 3.1
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 3.07
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.96
Identification of long noncoding RNAs in T-ALL cell lines 2.88
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.83
Primate-specific gene TMEM14B promotes cortical expansion and folding 2.79
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 2.76
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 2.74
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 2.74
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.68
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 2.67
RNA sequencing analysis of selumetinib-resistant CRC cells lines 2.66
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 2.58
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.54
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.54
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 2.54
Derivation and differentiation of haploid human embryonic stem cells 2.5
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 2.4
RNA splicing alteration on glioblastoma and normal neural stem cells 2.39
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.38
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.21
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 2.21
Specific molecular signatures underlie response to decitabine in CMML 2.21
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 2.16
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 2.14
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 2.14
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 2.08
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.06
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.06
Gene expression profile of CRC-derived HILEC 1.99
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.97
Hepatic transcriptome of pediatric hepatoblastoma. 1.91
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.88
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 1.88
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.84
ARID1A and ARID1B loss in HCT116 and TOV21G cells 1.84
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 1.68
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.68
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 1.67
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.59
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.59
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.53
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 1.48
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.48
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.48
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 1.47
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 1.44
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.43
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.41
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.36
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.34
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 1.27
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.26
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 1.23
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.21
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 1.14
HBEC-shp53-PCHD7 1.12
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.12
Trans-differentiation of human adult peripheral blood T cells into neurons 0.92
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.8
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 0.8
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 0.8
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.77
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.76
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.75
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.72
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.69
Direct Isolation and Characterization of Human Nephron Progenitors. 0.66
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 0.65
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 0.61
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.59
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.56
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.55
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.55
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.51
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.51
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.51
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.51
Leucegene: AML sequencing (part 6) 0.5
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.45
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.42
hNSCs siRNA NOVA2 0.39
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.34
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.34
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.28
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.24
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.19
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.14
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.14
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.14
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.13
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 0.07
BMS-470539 on human synovial fibroblasts 0.02
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.01
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.01
Impact on erythroid progenitor type on erythroid differntiation 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation